4.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TLRY Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.53
Aprire:
$4.51
Volume 24 ore:
2.74M
Relative Volume:
0.69
Capitalizzazione di mercato:
$619.11M
Reddito:
$858.28M
Utile/perdita netta:
$-1.34B
Rapporto P/E:
-0.3294
EPS:
-13.6608
Flusso di cassa netto:
$-75.96M
1 W Prestazione:
-1.96%
1M Prestazione:
-3.02%
6M Prestazione:
-38.36%
1 anno Prestazione:
-60.87%
Tilray Brands Inc Stock (TLRY) Company Profile
Nome
Tilray Brands Inc
Settore
Telefono
519.322.8800
Indirizzo
655 MADISON AVENUE, NEW YORK
Compare TLRY vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
TLRY
Tilray Brands Inc
|
4.50 | 642.50M | 858.28M | -1.34B | -75.96M | -13.66 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.45 | 57.90B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
36.36 | 42.89B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.60 | 43.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
75.81 | 31.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
487.61 | 22.35B | 3.17B | 1.29B | 1.01B | 27.09 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-02 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2026-01-27 | Iniziato | Canaccord Genuity | Hold |
| 2024-04-05 | Reiterato | Alliance Global Partners | Neutral |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-29 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Iniziato | Barclays | Underweight |
| 2021-11-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Ripresa | Cowen | Outperform |
| 2021-05-07 | Ripresa | Jefferies | Buy |
| 2021-05-06 | Iniziato | Canaccord Genuity | Buy |
| 2021-04-28 | Ripresa | BofA Securities | Buy |
| 2021-02-18 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-11-11 | Downgrade | Stifel | Hold → Sell |
| 2020-10-01 | Reiterato | MKM Partners | Neutral |
| 2020-09-21 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-05-12 | Reiterato | The Benchmark Company | Buy |
| 2020-04-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-04-09 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-13 | Iniziato | BofA/Merrill | Neutral |
| 2019-11-13 | Reiterato | The Benchmark Company | Buy |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Reiterato | Piper Jaffray | Overweight |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-08-14 | Reiterato | The Benchmark Company | Buy |
| 2019-07-17 | Iniziato | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Iniziato | Consumer Edge Research | Overweight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Iniziato | Oppenheimer | Perform |
| 2019-05-15 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Iniziato | Alliance Global Partners | Neutral |
Mostra tutto
Tilray Brands Inc Borsa (TLRY) Ultime notizie
Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here’s Why TLRY Is Still Down 47% YTD - AOL.com
Tilray Brands (NASDAQ:TLRY) Shares Up 3.6%Here's What Happened - MarketBeat
Tilray Brands Inc. stock rises Friday, outperforms market - MarketWatch
Canadian LPs expand presence in European cannabis as demand grows - MJBizDaily
Tilray Brands (NASDAQ:TLRY) Strategy Shift Shapes Cannabis Trends - Kalkine Media
Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell? - The Globe and Mail
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. - AOL.com
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners. - The Motley Fool
Why Does Tilray Brands (NASDAQ:TLRY) Face a New Cash Flow Test? - Kalkine Media
Tilray Keeps Closing Craft Breweries Because Its Strategy Never Made Sense in the First Place - VinePair
Tilray Expands Cannabis Cultivation Capacity in Canada, Europe to Meet International Demand - Cannabis Business Times
Tilray Brands (NASDAQ:TLRY) Shares Down 3.3%Should You Sell? - MarketBeat
Tilray Brands Inc. stock falls Thursday, underperforms market - MarketWatch
Tilray Brands (NASDAQ:TLRY): Business Updates Under Review - Kalkine Media
Tilray (TLRY) Results Versus Estimates: EPS Falls Short of Its Estimate for This Review; Market Move: Shares Finish 5.18% Down on the DayGAAP Earnings Report - Vinanet
Small caps to watch: Roots announces go-private deal, along with updates from Questerre Energy, Tilray and Aurora - The Globe and Mail
Stocks in play: Tilray Brands Inc. - The Globe and Mail
Tilray Brands Inc. - Baystreet.ca
Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way? - AOL.com
TLRY Looks 58.9% Undervalued on GF Value™ Amid Capacity Expansio - GuruFocus
Tilray Expands Global Cannabis Production Capacity to 275 Metric Tonnes - marketscreener.com
Tilray lifts annual cannabis cultivation capacity to about 275 metric tonnes (TLRY:NASDAQ) - Seeking Alpha
Tilray Strengthens Global Medical Cannabis Leadership with Major Production Increase to Meet International Demand - marketscreener.com
What Should Markets Watch at Tilray Brands (NASDAQ:TLRY) Now? - Kalkine Media
Tilray Brands (NASDAQ:TLRY) Stock Price Up 8.1%Should You Buy? - MarketBeat
Tilray Brands Inc. stock rises Wednesday, outperforms market - MarketWatch
Tilray (TLRY) Results Check: Reported EPS Misses Expectations in the Current Update; Share Response - Vinanet
Tilray Brands (NASDAQ:TLRY): The Cannabis Story Is Getting Complicated - Kalkine Media
Could Tilray Brands (NASDAQ:TLRY) Gain From Its UK Push? - Kalkine Media
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development - Sahm
Tilray (TLRY) Results and Estimates: The Available Earnings Metric Delivers a Miss in the Current Update; Market Reaction: Shares Fall 0.22%Earnings Revision Downgrade - Vinanet
Tilray Brands (NASDAQ: TLRY): Key Catalysts Come Into Focus - Kalkine Media
Tilray Brands (NASDAQ:TLRY): What Could Shift the Story? - Kalkine Media
BrewDog Unwraps Its 2026 Advent Calendar - markets.businessinsider.com
BrewDog's Christmas box packs 24 beers and a glass made for this year's edition - Stock Titan
Tilray Medical Welcomes Progress in Germany’s Medical - GlobeNewswire
Why Is Tilray Brands (NASDAQ:TLRY) in Focus as Rescheduling Hopes Reshape the Cannabis Mood? - Kalkine Media
Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Shares Down 4.1%Here's What Happened - MarketBeat
Tilray Medical Accelerates Commercial Expansion in UK With Direct-to-Patient Launch - Cannabis Business Times
Tilray Brands Inc. stock falls Monday, underperforms market - MarketWatch
Why Is Tilray Brands (TSX:TLRY) Making Headlines Among Cannabis Stocks? - Kalkine Media
Tilray Brands (NASDAQ:TLRY) Shares Draw Attention Amid Global Expansion Push - Kalkine Media
Tilray Brands, Inc. - Baystreet.ca
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub - markets.businessinsider.com
An 800-square-foot brewpub opens on Long Island’s North Shore—who’s behind it? - Stock Titan
Weekly Recap: Beverage int'l sales and Hi*Ball energy partnership - TradingView
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary - The Globe and Mail
A new UK route for medical cannabis patients runs through Lyphe - Stock Titan
Tilray Brands (NASDAQ:TLRY): Why Is Diversified Platform in Focus Today? - Kalkine Media
Tilray Brands (NASDAQ:TLRY) stock in focus as cannabis beverage launch draws attention - Kalkine Media
Tilray Brands Inc Azioni (TLRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tilray Brands Inc Azioni (TLRY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Merton Carl A | Chief Financial Officer |
Aug 26 '26 |
Option Exercise |
0.00 |
168,452 |
0 |
276,646 |
| Gendel Mitchell | Global General Counsel |
Aug 26 '26 |
Option Exercise |
0.00 |
160,304 |
0 |
258,392 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Aug 26 '26 |
Option Exercise |
0.00 |
178,221 |
0 |
288,657 |
| Gendel Mitchell | Global General Counsel |
Aug 06 '26 |
Buy |
4.43 |
2,500 |
11,075 |
124,883 |
| Merton Carl A | Chief Financial Officer |
Aug 04 '26 |
Buy |
4.62 |
10,000 |
46,200 |
139,753 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Aug 03 '26 |
Buy |
4.78 |
2,500 |
11,950 |
141,285 |
| SIMON IRWIN D | President and CEO |
Jul 30 '26 |
Option Exercise |
0.00 |
117,647 |
0 |
801,666 |
| SIMON IRWIN D | President and CEO |
Jul 29 '26 |
Option Exercise |
0.00 |
428,448 |
0 |
911,097 |
| Merton Carl A | Chief Financial Officer |
Jul 30 '26 |
Option Exercise |
0.00 |
16,656 |
0 |
138,914 |
| Merton Carl A | Chief Financial Officer |
Jul 29 '26 |
Option Exercise |
0.00 |
60,417 |
0 |
152,467 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):